These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 33083453

  • 1. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
    Chen K, Li Z, Zhang M, Wang B, Peng T, Shen Y, Zhang J, Ye J, Liu Y, Tang D, Peng M, Ma D, Xiao Z, Zhang Y, Jin W, Li X.
    Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453
    [Abstract] [Full Text] [Related]

  • 2. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W, Wen X, Su K, Gou W.
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y, He X.
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [Abstract] [Full Text] [Related]

  • 4. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 6. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C, Chen B, Jiao A, Li F, Sun N, Zhang G, Zhang J.
    BMC Cancer; 2018 Nov 28; 18(1):1179. PubMed ID: 30486878
    [Abstract] [Full Text] [Related]

  • 7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, Yun JP, Xu RH, Cai QQ, Xie D.
    Theranostics; 2019 Nov 28; 9(7):1965-1979. PubMed ID: 31037150
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z.
    Artif Cells Nanomed Biotechnol; 2019 Dec 28; 47(1):3885-3895. PubMed ID: 31561723
    [Abstract] [Full Text] [Related]

  • 9. LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway.
    Li H, Wu Y, Wang R, Guo J, Yu Q, Zhang L, Zhao H, Yang H.
    Genes Genomics; 2022 Jan 28; 44(1):133-144. PubMed ID: 34778942
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z, Xiong Z, Li R, Liang H, Jia C, Deng M.
    Biomed Pharmacother; 2018 Aug 30; 104():102-109. PubMed ID: 29772429
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 13. Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma.
    Wu J, Huang WJ, Xi HL, Liu LY, Wang ST, Fan WZ, Peng BG.
    Aging (Albany NY); 2019 Jun 04; 11(11):3432-3444. PubMed ID: 31163018
    [Abstract] [Full Text] [Related]

  • 14. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process.
    Hu WY, Wei HY, Liu LY, Li KM, Wang RB, Xu XQ, Feng R.
    IUBMB Life; 2020 Aug 04; 72(8):1686-1697. PubMed ID: 32311821
    [Abstract] [Full Text] [Related]

  • 15. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
    Pan Y, Qin T, Yin S, Zhang X, Gao X, Mu L.
    Biomed Pharmacother; 2017 Mar 05; 87():669-677. PubMed ID: 28088733
    [Abstract] [Full Text] [Related]

  • 17. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 05; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 18. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
    Dong J, Teng F, Guo W, Yang J, Ding G, Fu Z.
    Cell Physiol Biochem; 2018 Jul 05; 51(5):2262-2274. PubMed ID: 30537734
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z, Xia X, Lu J.
    Med Sci Monit; 2020 Jan 19; 26():e919241. PubMed ID: 31955177
    [Abstract] [Full Text] [Related]

  • 20. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
    Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia X, Zhao W, Huai W, Qiu Y, Sun L, Han L.
    Sci Rep; 2014 Sep 01; 4():6248. PubMed ID: 25175916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.